Juan Carlos Ruiz Cobo

🧵 HILO: Neuromoduladores en Gastroenterología 1️⃣ Los Trastornos de la Interacción Cerebro-Intestino (TICI) afectan el procesamiento central y periférico de estímulos en el eje cerebro-intestino. Incluyen dispepsia funcional, gastroparesia y SII. ¡Su tratamiento clave son los neuromoduladores! 🧠🦠 Todo lo que desees saber aqui sciencedirect.com/science/articl… @gastromx @motilidad @CidemoArgentina @ASENEM_ @aeg @drprapul @DraBarba @DeMadaria @coss_enriquemd @GastroMty @CMIMorg @pepebandera1 @velardemd @ConchaAlejandro @OPGEgastro @OxytocinLau

#AEEH2025. ➡️'Hepatolotoxicidad por inhibidores de CDK4/6 en cáncer de mama metastático (CMM)', con @mar_riveiro (ganadora de una de las #Becas Gilead-AEEH). ✔️Un estudio multicéntrico que todavía está en marcha. 🗣️"El manejo del #DILI por CDKi es heterogéneo, y su estandarización es una necesidad de futuro dada la reciente aprobación de #ribociclib y #abemaciclib en el contexto adyuvante, explica Mar. @LHuvh @CIBERehd #50CongresoAEEH

🆕 @AmerGastroAssn Guidelines for Prevention & Treatment of Hepatitis B Virus Reactivation in At-Risk Individuals ▪️HBsAg (+) ▪️HBsAg (-), HBcAB (+) 🚨B-cell depleting agents 🚨Anthracycline 🚨Anti-TNF 🚨Anti-IL6 🚨Cytokine inh 🚨CAR-T 🚨TACE 🚨JAKi 🔗 gastrojournal.org/article/S0016-…

🚨🚨Happy to share our last paper!!!🚨🚨 Non-invasive assessment of severe liver fibrosis in patients with Fontan-associated liver disease: The VALDIG-EASL FONLIVER cohort - Journal of Hepatology journal-of-hepatology.eu/article/S0168-…

ACG Clinical Practice guideline on H. pylori was published in ⁦@AmJGastro⁩ today. Visual abstract gives a great summary. Thanks to my co authors! ⁦@ShailjaShahMD⁩

🗞️New article ▶️effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients @APandT @DigestivoHuvv @_ibima @JCRCobo @DrJLCalleja @Mariabutif 👇 onlinelibrary.wiley.com/doi/10.1111/ap…

Efficacy and safety of carvedilol in cirrhosis patients with uncomplicated ascites without high-risk esophageal varices, RCT Carvedilol less Complicated ascites Refractory ascitis Mortality 90% men #EASLCongress #WeShareEASL

Elena Vargas-Accarino presenting and discussing her poster on hepatitis C screening in primary care setting - EASL Congress 2024

🆕Article in press❕ Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase 3 randomized trial #OpenAccess here👉journal-of-hepatology.eu/article/S0168-… #LiverTwitter

PoCUS en lesión renal asociado a cirrosis en @AEcodigest por el Dr @Tubulocentric Interesante charla👈 💡La ecografía aporta información en el paciente cirrotico, más allá del cribado, ascitis o Trombosis ♦️ Importante: evaluar la congestión del paciente cirrótico #AEED2024

🟪NEW Article in press❕ Sarcopenia evaluated by EASL/AASLD computed tomography-based criteria predicts mortality in patients with #cirrhosis: a systematic review and meta-analysis 🔓#OpenAccess at 👉jhep-reports.eu/article/S2589-… #LiverTwitter @EASLedu @AASLDtweets

Happy to share results from Hepa-C registry! @AEEHLiver SOF/VEL/VOX is an effective rescue therapy💊 for patients with #HCV 🦠infection who failed to first line therapies without differences between SOF/VEL or GLE/PIB prior treatment >>> 88.6% SVR onlinelibrary.wiley.com/doi/10.1111/ap…

Fantastic collaboration with 🇪🇸 #POCUS experts! @Derasnef @EmiliSanAlv @JaimeMazonRuiz @Tubulocentric Acute Kidney Injury and Point-of-Care Ultrasound in Liver Cirrhosis: Redefining Hepatorenal Syndrome academic.oup.com/ckj/article/do…

Adriana Palom from our Liver Unit @LHuvh presenting the influence of RNA-HDV on clinical events of #HDV patients at #AEEH2024 @VHIR_ @CIBERehd @AEEHLiver

Read Open Access "An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor-induced liver injury" by Riveiro-Barciela at bit.ly/42BlEzt #livertwitter #immunotherapy

Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU - ScienceDirect sciencedirect.com/science/articl…

Inaugurem la setmana de les malalties hepàtiques a Catalunya! @LHuvh @vallhebron @AEEHLiver

No todo van a ser sesiones en bata😷, gran noche del talento joven digestivo del @vallhebron ✨🩺🚑 @LHuvh @cherreradeguise @Albajmasip @alcala_glez_LG @sergio_g_mm @SerraXevi @elecesmar

🆕Article in press❕ The adjusted prevalence of hepatitis delta virus (#HDV) in 25 countries and territories 🔓#OpenAccess at👉journal-of-hepatology.eu/article/S0168-… @PolarisObserv #LiverTwitter

Venga Barceloneses, este año es el primero que corremos en la ciudad! Vamos a quedarnos por detrás de Madrid y Alicante??🏃🏃🏃 Apúntate ya! ⤵️